
Above-Market Lease with Landlord Doctors Costs BioReference $9.85 Million
In this month’s Labs in Court roundup, BioReference pays big to settle kickback allegations, among several other kickback-related cases.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LAB INDUSTRY REPORT
NATIONAL LAB REPORTER
In this month’s Labs in Court roundup, BioReference pays big to settle kickback allegations, among several other kickback-related cases.
The OIG’s new Fraud Alert can help labs and other providers steer clear of potentially suspect arrangements with telemedicine companies.
NY federal court ruling sheds light on what constitutes “remuneration” banned by the Anti-Kickback Statute.
New OIG Advisory Opinion offers valuable insight into where the agency draws the line on free genetic tests.
Of this month’s four Labs in Court cases, three involved kickbacks resulting in widely varying penalties.